Risk Factors of Porphyria Cutanea Tarda (PCT)

Factors Associated With Porphyria Cutanea Tarda in Patients Infected With Hepatitis C Virus

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00213772

Enrollment

280

Registered

2005-09-21

Start date

1999-05-31

Completion date

Unknown

Last updated

2005-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Porphyria Cutanea Tarda

Keywords

Porphyria cutanea tarda, hepatitis C, hemochromatosis

Brief summary

Comparison of patients with documented PCT and HCV infection, documented PCT without HCV, HCV infection without PCT and controls without HCV or PCT. Single blood + urine sample uptake to investigate : mutations in HFE gene, uroporphyrinogen decarboxylase activity, HCV genotye, history of disease.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Porphyria cutanea tarda /HCV negative Porphyria cutanea tarda/ HCV positive HCV positive HCV negative controls

Outcome results